CAS Scientists Succeeded in Expressing Key Proteins in SARS Virus

摘要

In cooperation with colleagues from other labs, researchers of the CAS Shanghai Institutes of Materia Medica (SIMM) and the CAS Institute of Biochemistry and Cell Biology (IBCB) have made progress in gene cloning, protein expression, structural analysis, and drug design in regard to SARS virus. This was announced May 16 by Pei Gang, director of the CAS Shanghai Institutes for Biological Sciences, parent institution of the two institutes. The scientists have fulfilled the task of expressing and preliminarily verifying three key proteins in SARS virus. One of them is being used for in vitro anti-SARS drug screening. The achievement is hailed as another significant step in SARS research after the SARS virus isolation and its whole genome sequencing. The findings will be fully reported in the June 5 issue of ACTA PHARMACOLOGICA SINICA.